Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
0.9425
-0.0154 (-1.61%)
Jun 15, 2026, 4:00 PM EDT - Market closed
Rein Therapeutics Market Cap
Rein Therapeutics has a market cap or net worth of $87.69 million as of June 16, 2026. Its market cap has increased by 102.99% in one year.
Market Cap
87.69M
Enterprise Value
88.17M
1-Year Change
102.99%
Ranking
Category
Stock Price
$0.94
Market Cap Chart
Since June 29, 2017, Rein Therapeutics's market cap has decreased from $158.87M to $87.69M, a decrease of -44.80%. That is a compound annual growth rate of -6.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 87.69M | 187.58% |
| Dec 31, 2025 | 30.49M | -38.81% |
| Dec 31, 2024 | 49.83M | 234.56% |
| Dec 29, 2023 | 14.89M | 38.39% |
| Dec 30, 2022 | 10.76M | -78.89% |
| Dec 31, 2021 | 50.98M | 20.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inovio Pharmaceuticals | 90.13M |
| ProMIS Neurosciences | 90.13M |
| Atara Biotherapeutics | 89.88M |
| PolyPid | 89.45M |
| Champions Oncology | 88.67M |
| Biomea Fusion | 86.76M |
| ImmuCell | 86.22M |
| Adicet Bio | 85.32M |